Neurolixis' Incubator/Accelerator Round

Neurolixis raised a round of funding on February 01, 2012. Investors include JLabs.

Neurolixis is an early-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of human central nervous system diseases including Parkins…

Articles about Neurolixis' Incubator/Accelerator Round: